Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death

Table 4 Multivariate Analysis of Overall Survival, Cox Model (n = 130)

Covariate	Comparison	Hazard Ratio for death [CI 95%]	P N = 127
HER-2 positive patients treated with trastuzumab	Yes vs No	0.49 [0.29;0.83]	0.00810
KPS	≥ 70 vs. < 70	0.56 [0.37; 0.85]	0.00578

ISSN: 1471-2407